The week in review


It’s been a busy week in the world of pharmacy…

The TGA announced that several ranitidine-containing products including Zantac have been removed from the Australian market due to contamination with an impurity called N‑nitrosodimethylamin.

Some interesting studies this week included new research led by the University of Sydney which showed a sharp drop in codeine poisonings and sales since the controversial February 2019 upschedule; and a review which identified areas of pharmacy-related research that were not conducted to the highest standard or where reporting is inadequate. Another study found troubling lack of knowledge about emergency contraception among schoolies.

The profession made the mainstream media a number of times again, including in one article which suggested many pharmacists were treating opioid replacement therapy patients poorly and perpetuating stigma; and pharmacists including the Guild‘s Anthony Tassone were critical of a Nine News piece which appeared on Monday night, featuring former ACCC head Graeme Samuel calling for deregulation of the sector.

FIP issued a statement on self care. There’s an “unprecedented” measles cluster in Perth. South Australia is cracking down on vaping, and as of October 1 the employee pharmacy award went up.

And we found out who AJP readers voted the most influential people in pharmacy: click here for the full list! Congratulations to all.

Previous Raise the rate, says CHF
Next Health ‘blitz’ on ORT

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.